Cresco Labs Announces Filing of Preliminary Base Shelf Prospectu
CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. ( CRLBF
Loading...
Loading...
) (“Cresco Labs” or the “Company”) (CSE: CL) , one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has filed and received a receipt for a preliminary short form base shelf prospectus (the “Shelf Prospectus”) with the securities commissions in each of the provinces of Canada, except Québec.
“Although we have no immediate plans to raise capital through this shelf filing, we believe it’s prudent to give the Company the flexibility to access capital in the future when opportunities emerge to continue executing on our growth strategies,” said Cresco Labs ( CRLBF
Loading...
Loading...
) CEO and Co-founder Charlie Bachtell. “We have consistently demonstrated strong capital stewardship and we expect to continue driving shareholder value through our capital deployment.”
The Shelf Prospectus, when made final, will allow the Company to offer up to C$500,000,000 of subordinate voting shares, debt securities, subscription receipts, warrants, and units, or any combination thereof, from time to time during the 25-month period that the (final) Shelf Prospectus is effective. The Company filed this Shelf Prospectus in order to maintain financial strength and flexibility going forward but has not entered into any agreements or arrangements to authorize or offer any securities at this time. The specific terms of any future offering of securities, including the use of proceeds from any offering, will be established in a prospectus supplement to the Shelf Prospectus, which supplement will be filed with the applicable Canadian securities regulatory authorities.
